Proteros Appoints New Chief Financial Officer
News Oct 10, 2012
Arnd Christ has more than 12 years of international experience as a CFO in the biotechnology industry, with responsibilities in finance, operations, legal affairs and investor relations. He has successfully conducted a number of financial transactions and has a broad experience in all aspects of accounting and controlling.
Arnd Christ has a successful track record in various biotechnology companies and has most recently worked as Chief Financial Officer at MediGene AG, a listed biotechnology company in Germany. Formerly he served as CFO in biotechnology companies in Germany and Switzerland, as well as Finance Director within the Hoechst AG Group. Mr. Christ earned his master’s degree in Business Administration at Julius Maximilian University Würzburg.
"I am delighted to be joining such an accomplished management team that has built Proteros into a profitable business" commented Arnd Christ. "I am looking forward to helping the team execute on their growth strategy and in particular, the continued expansion into integrated lead discovery collaborations."
Dr. Torsten Neuefeind, Chief Executive Officer and founder of Proteros, stated: "We are very pleased to have Arnd join Proteros. His extensive international finance experience in Biotech as well as his solid CFO-background will be a valuable skill set to further support Proteros’ growth strategy in the collaborative research business and in higher value lead discovery partnerships."
Scientists Develop a Synthetic Solution to Combat Dwindling Supply of Cancer and HIV DrugNews
Supplies of a promising drug for cancer, HIV and possibly other diseases is dwindling, and scientists have struggled to extract more from the marine creatures who produce it. Now, chemists have a synthetic solution.READ MORE
Neutrons Observe Vitamin B6-dependent Enzyme Activity Useful for Drug DevelopmentNews
Scientists performed neutron structural analysis of a vitamin B6-dependent protein, potentially opening avenues for new antibiotics and drugs to battle diseases such as drug-resistant tuberculosis, malaria and diabetes.READ MORE
Biomarker for Glioblastoma Predicts Clinical Course and Sensitivity to TreatmentNews
Scientists validate a biomarker indicative of patients with Glioblastoma prognosis and likely response to specific therapies.READ MORE
Comments | 0 ADD COMMENT
Annual Conference on Antimicrobials and Drug Resistance
Sep 24 - Sep 25, 2018
1st Alpine Winter Conference on Medicinal and Synthetic Chemistry
Jan 28 - Feb 01, 2018